CAH Panel 7 (21-Hydroxylase Deficiency Therapeutic Monitoring)
Test Code
15277
82157, 83498, 84403
Clinical Significance
CAH Panel 7 (21-Hydroxylase Deficiency Therapeutic Monitoring)
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
17-Hydroxyprogesterone
Androstenedione
Testosterone, Total, MS
Androstenedione
Testosterone, Total, MS
Methodology
Chromatography/Mass Spectrometry
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
See Laboratory Report